MRK monthly performance report
Monthly MRK research: returns, drawdown, relative strength, seasonality, and key stats.
MRK monthly report
—
Key takeaways
- Merck & Co. (MRK) closed August 2026 at $128.33, down 1.44% for the month and +58.84% over the trailing 12 months.
- Year-to-date, MRK is +21.92%, outperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading +14.53% versus its 200-day moving average ($112.05), a bullish technical signal.
- Over the past three years, MRK has underperformed the S&P 500 by −50.07%, with a relative strength index reading of 70.8.
- Win rate over the trailing 39 months stands at 41% — 16 positive months versus 23 negative months.
Merck & Co. ended August 2026 at $128.33, posting a monthly return of −1.44%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −4.48%.
The current quarter stands at +1.61% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +14.53% versus the 200-day moving average ($112.05).
Year-to-date, MRK is +21.92% against SPY +12.89%, a gap of +9.03%. The stock is currently −4.98% below its 52-week high, with maximum 3-year drawdown at −44.74%.
| Period | MRK | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.26% | −0.20% | +0.46% |
| 1 Week | −2.65% | +3.90% | −6.55% |
| 1 Month | −1.44% | +3.05% | −4.48% |
| 3 Months | +17.54% | +7.11% | +10.43% |
| 6 Months |